Insider Buying: Option Care Health (NASDAQ:OPCH) CEO Purchases $264,750.00 in Stock

Option Care Health, Inc. (NASDAQ:OPCH) CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the transaction, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $20.45 on Thursday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The business has a 50-day moving average of $28.55 and a 200-day moving average of $30.66. The stock has a market capitalization of $3.21 billion, a price-to-earnings ratio of 15.85, a PEG ratio of 1.15 and a beta of 0.68. Option Care Health, Inc. has a fifty-two week low of $18.01 and a fifty-two week high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OPCH. Morgan Stanley set a $28.00 price target on shares of Option Care Health in a research note on Wednesday. Citizens Jmp reaffirmed a “market outperform” rating and issued a $38.00 target price (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. TD Cowen cut their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research note on Friday, May 1st. UBS Group reduced their price target on Option Care Health from $45.00 to $39.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Truist Financial set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $31.25.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Large insider purchases by management — CEO John Rademacher bought 12,500 shares (~$21.18 avg) and Director Harry Jansen Kraemer Jr. bought 36,610 shares (~$21.41 avg), increasing their holdings. Insider buys often signal management confidence and can support sentiment. Read More.
• Positive Sentiment: Morgan Stanley reaffirmed an “overweight” view on OPCH, maintaining institutional support from a major broker despite recent headwinds. Read More.
• Neutral Sentiment: Chief Growth Officer transition announced (Christopher L. Grashoff departing) — routine leadership change that could cause short?term execution questions until a successor is named. Read More.
• Neutral Sentiment: Management will present at the Bank of America Health Care Conference (May 12) — an opportunity for management to provide clarity or updated guidance; could be a catalyst either way. Read More.
• Neutral Sentiment: Recent Q1 results were mixed: EPS of $0.40 beat the $0.37 estimate, but revenue of $1.35B missed the $1.39B consensus and FY?2026 EPS guidance was set at $1.82–$1.92 — leaves upside dependent on margin gains and execution. Read More.
• Negative Sentiment: Multiple securities?fraud investigations announced by several law firms (Schall Law, Howard G. Smith, Frank R. Cruz, Levi & Korsinsky, Block & Leviton) alleging potentially misleading disclosures related to the Q1 report and guidance adjustments — this raises legal, regulatory and reputational risk and is likely the primary driver of today’s selling and elevated volume. Read More.

Institutional Trading of Option Care Health

A number of hedge funds have recently modified their holdings of the stock. Cornerstone Investment Partners LLC grew its stake in Option Care Health by 3.4% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company’s stock valued at $311,000 after buying an additional 318 shares during the last quarter. Sheets Smith Wealth Management lifted its position in Option Care Health by 1.3% during the fourth quarter. Sheets Smith Wealth Management now owns 26,167 shares of the company’s stock worth $834,000 after acquiring an additional 326 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 23.5% during the fourth quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock worth $55,000 after acquiring an additional 326 shares during the period. Fifth Third Bancorp grew its position in shares of Option Care Health by 21.9% in the fourth quarter. Fifth Third Bancorp now owns 2,328 shares of the company’s stock valued at $74,000 after purchasing an additional 419 shares during the last quarter. Finally, Andina Capital Management LLC grew its position in shares of Option Care Health by 2.6% in the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock valued at $520,000 after purchasing an additional 419 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.